Drug intelligence / Profile preview

AC-1

Development stage
Preclinical
Administration
Oral
01

Overview

AC-1 is an extracellular polysaccharide produced by *Acetobacter polysaccharogenes*, primarily composed of (1,4)-beta-D-glucan with branches of glucosyl residues. It functions as an immunomodulator, enhancing antitumor activities by inducing the production of interleukin (IL)-12 p40 and tumor necrosis factor-alpha (TNF-alpha) by macrophage cell lines through Toll-like receptor-4 (TLR4) signaling. Preclinical studies in murine B16 melanoma models (MHC class I-negative B16L and MHC class I gene-transfected B16K(b) cells) have shown that AC-1 retards tumor growth. Its antitumor mechanism involves augmenting natural killer (NK) cell activity and cytotoxic T-lymphocyte responses, suggesting potential prophylactic application for human neoplasms irrespective of MHC class I expression levels.

02

Targets

TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on AC-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AC-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call